探討MAGE A4 自體抗體作為腫瘤標記之可行性

中山醫學大學機構典藏 CSMUIR > 醫學院 > 生化微生物免疫研究所 > 博碩士論文 > Item 310902500/2376

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/2376

Title:	探討MAGE A4 自體抗體作為腫瘤標記之可行性 Study of MAGE A4 autoantibody as a tumor marker for diagnosis
Authors:	湯美慧 Mee-Wai,Tong
Contributors:	中山醫學大學:醫學院;生化暨生物科技研究所;陳凌雲
Keywords:	MAGE A4自體抗體;腫瘤標誌 MAGE A4autoantibody;tumor marker
Date:	2010
Issue Date:	2010-10-14T04:35:26Z (UTC)
Abstract:	子宮頸癌、卵巢癌一直名列女性癌症死亡十大原因，但在婦科疾病中以子肌瘤、子肌腺症、子宮內膜異位症最為常見，這些病復發率甚高。臨床上，如果能以血清學的方式檢查，早期診斷出疾病，早期治療，可避免症狀惡化。 SEREX (Serological identification of antigen by recombinant expression cloning)的實驗方法，檢測癌症患者血清中的自體抗體可辨識腫瘤相關抗原(Tumor associated antigen, TAA)，來協助診斷癌症的變化或癒後追蹤的工具。有文獻指出，在癌症形成早期，就可從血清中偵測到高效價的自體抗體。過去本實驗室已製備了數個腫瘤相關抗原，其中p53在105位婦科患者的陽性率達23.81%，而IMP1在55位子宮相關疾病患者中陽性率14.29%。因此，藉由cancer Immunome Database 搜尋與卵巢相關的腫瘤抗原，選擇製備MAGE A4第75至201的胺基酸所表達的蛋白片段，以酵素免疫法偵測90位正常人血清中之自體抗體，發現表現量都很高，再以西方墨點法分析證實血清中有對抗MAGE A4的抗體存在。另外，再選擇在前段第1至74的胺基酸及後段第202至317的胺基酸製備重組蛋白，同樣可偵測到正常人血清含有MAGE A4抗體，顯示MAGE A4 不適合作為腫瘤標記。 Cervical cancer and ovary cancer are the leading cause of death from female cancer in Taiwan. The majority of gynecological diseases, including adenomyosis, myoma, leiomyoma, endometriosis and endometrioma, are always with high recurrences .There is great need to have a Serologic test to detect those of gynecological diseases and use for routine. SEREX method involves the identification of TAAs by screening patient sera, because of autoantibody against TAAs found in patient serum. At early stage of tumorigenesis, high titer of autoantibodies can be detected in patients’ serum. Previously, many recombinant TAAs have been prepared in study of gynecological disease. Autoantibody to p53 was positive rate with 23.81% and IMP1 autoantibody was 14.29%. We select another TAA, MAGE A4, which associated with ovary tumor searching from Cancer immunome database to improve our diagnosis. Autoantibody to MAGE A4 show high level in normal individual with ELISA assay, followed by western blotting, confirmed that autoantibody was in normal individual. Further study, we cloned two recombinant proteins with different location at MAGE A4. Finally, by Western Blotting, autoantibody to MAGE A4 was detected in normal individual. This result suggests that MAGE A4 can not be used as tumor marker in diagnosis.
URI:	https://ir.csmu.edu.tw:8080/handle/310902500/2376
Appears in Collections:	[生化微生物免疫研究所] 博碩士論文

Files in This Item:

File	Description	Size	Format
index.html	碩士論文	0Kb	HTML	340	View/Open

Loading...